FindTrial
Sign In

Optimization of ovarian tissue culture using novel bioreactor

Validation of bioreactor in improving ovarian tissue viability and quality

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/050357
Enrollment
10
Registered
2023-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N948- Other specified conditions associated with female genital organs and menstrual cycle

Interventions

Intervention1: Bioreactor in vitro device: Used for in vitro culture of ovarian tissue in fertility restoration. Device will not be used on patient directly. It will be used on ovariectomized tissue f

Sponsors

Merck India Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Females undergoing oophorectomy/ovariectomy as part of their treatment plan for medical conditions will be recruited for the study. Only ovarian tissue will be used for the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
This study will help to evaluate the application of bioreactor culture system for in-vitro folliculogenesis and oocyte maturation using human ovarian tissuesTimepoint: 1 year—

Secondary

MeasureTime frame
This study will help to provide an option of fertility preservation of women using ovarian tissuesTimepoint: 1 year—

Countries

India

Contacts

Public ContactDr Satish Kumar Adiga

Kasturba Medical College Manipal

satish.adiga@manipal.edu08202922320

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026